Log In
BCIQ
Print this Print this
 

MYK-491 (formerly DCM-1)

  Manage Alerts
Collapse Summary General Information
Company MyoKardia Inc.
Description 
Molecular Target
Mechanism of Action 
Therapeutic Modality 
Latest Stage of DevelopmentPreclinical
Standard IndicationCardiomyopathy
Indication DetailsTreat dilated cardiomyopathy (DCM)
Regulatory Designation
PartnerSanofi

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today